Fig. 3From: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseFlow diagram depicting patient flow in each simulated scenario. Published test performances allowed prediction of true and false positive and negative rates for detection of advanced fibrosis (≥F3) in each scenarioBack to article page